Hexima scores with DuPont

By Dylan Bushell-Embling
Thursday, 07 August, 2008

Hexima [ASX: HXL] is to partner with chemical multinational DuPont to develop a fungal disease resistance technology in crops such as corn and soybeans.

Under the agreement Hexima and DuPont subsidiary Pioneer Hi-Breed will combine a series of intellectual properties to create the technology. Pioneer will use its gene-shuffling technology while Hexima will offer its gene delivery technology.

Pioneer will own commercialisation rights for corn and soybeans and Hexima will manage all other crops. The first target is broad-spectrum disease resistance in corn, especially stalk rot.

Pioneer has agreed to purchase a five per cent stake in Hexima, or four million shares, at a price of $1.50 per share.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd